Competitive antagonists shift the dose-effect curve for an agonist [e.g. the endogenous neurotransmitter] to the right, but this effect can eventually be overcome by enough agonist concentration.
Competitive antagonists shift the dose-effect curve for an agonist [e.g. the endogenous neurotransmitter] to the right, but this effect can eventually be overcome by enough agonist concentration.
We have detected that you are from “France”. You have the option of switching the language to French, if you would prefer that?.
Please enter your details below.
